TGA
Zantac cancer court cases loom
Mass international litigation could cost pharma companies up to $66 billion, say analysts Pharmaceutical companies which have sold antacid drug Zantac (ranitidine) could face multi-billions of dollars in damages if …
Misorientation recall
Some Trikafta tablets may be incorrectly located in their packs, warns the TGA The TGA has announced a product defect correction regarding cystic fibrosis treatment Trikafta, noting that in some …
TGA ‘hysterical’ over ivermectin, says pharmacist and GP
A GP, pharmacist and pharmacy owner says he “can’t believe how badly doctors have reacted” to his application to remove the ban on ivermectin for COVID-19 Victorian pharmacist, GP and …
Green light for bivalent booster
First bivalent COVID-19 vaccine approved for use in Australia The TGA has provisionally approved Moderna’s Spikevax bivalent COVID-19 vaccine for use as a booster dose in adults 18 years and …
The hot topics
In this podcast, pharmacists discuss a range of important topics including regulation, genomics, homeopathy and career barriers Our podcast host Carlene McMaugh has collated a series of interviews with leading …
Reduce or run out
Healthcare professionals urged to conserve tenecteplase (Metalyse) in wake of shortage due to surging global demand, to maintain continuity of supply for patients Boehringer Ingelheim Australia has advised the TGA …
Provisional determination for new COVID treatment
Sabizabulin’s sponsor can now seek provisional registration for the treatment of COVID-19, says the TGA The Therapeutic Goods Administration has announced that it has granted a provisional determination to Adjutor …
Downschedule decision on allergic rhinitis drugs
Bid to downschedule existing fixed-dose combination products containing both azelastine and fluticasone propionate rejected in interim decision An application to amend the existing S2 entries for azelastine and fluticasone propionate …
Blood pressure drug recall
Potential carcinogen traces prompts action as “precautionary measure” Pharmaceutical company Pfizer is recalling some batches of hypertension medications containing quinapril and pausing supply of others, according to an alert from …
TGA fines vape importer almost $3k
Individual accused of false customs declaration A person based in Western Australia has been fined $2,664 by the TGA for allegedly illegally importing liquid nicotine for vaping products. The infringement …
Ozempic shortages until December
Diabetes medication shortfall “worse than ever” The long-running shortage of diabetes drug Ozempic (semaglutide) looks set to continue until at least the end of the year, according to a revised …
Fines over COVID-19 masks, RATs
The Federal court has ordered one company to pay $80k over face mask breach, while another has been fined $67k for failing to provide information on its RATs The TGA …